Furthermore, protein levels corresponding to FOXC1 target genes were lower in Luminal B patients with high EZH2 and low FOXC1 expression, supporting our hypothesis that a FOXC1-driven transcriptional program is suppressed by EZH2 specifically in Luminal B breast cancer. The gene discussed is EZH2; the disease is breast cancer.